These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 6543245)
1. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine. Agut J; Coviella IL; Wurtman RJ Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245 [TBL] [Abstract][Full Text] [Related]
2. Effects of hypoxia and cytidine (5') diphosphocholine on the concentrations of dopamine, norepinephrine and metabolites in rat hypothalamus and striatum. Saligaut C; Daoust M; Moore N; Boismare F Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):25-33. PubMed ID: 3579424 [TBL] [Abstract][Full Text] [Related]
3. Cytidine (5')diphosphocholine modulates dopamine K(+)-evoked release in striatum measured by microdialysis. Agut J; Ortiz JA; Wurtman RJ Ann N Y Acad Sci; 2000; 920():332-5. PubMed ID: 11193174 [TBL] [Abstract][Full Text] [Related]
4. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment. Nomura Y; Komori T; Okuda S; Segawa T Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682 [TBL] [Abstract][Full Text] [Related]
5. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation. Millington WR; Wurtman RJ Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193 [TBL] [Abstract][Full Text] [Related]
6. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions. Bacopoulos NG; Roth RH Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869 [TBL] [Abstract][Full Text] [Related]
7. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903 [No Abstract] [Full Text] [Related]
8. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats. Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859 [TBL] [Abstract][Full Text] [Related]
9. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255 [TBL] [Abstract][Full Text] [Related]
10. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum. Moleman P; Bruinvels J; van Valkenburg CF J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101 [No Abstract] [Full Text] [Related]
11. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs. Radhakishun FS; Korf J; Venema K; Westerink BH Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209 [TBL] [Abstract][Full Text] [Related]
12. Effects of CDP-choline on striatal dopamine level and behavior in rats. Shibuya M; Kageyama N; Taniguchi T; Hidaka H; Fujiwara M Jpn J Pharmacol; 1981 Feb; 31(1):47-52. PubMed ID: 7253343 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine. Toru M; Mataga N; Takashima M; Nishikawa T Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073 [TBL] [Abstract][Full Text] [Related]
14. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method. Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596 [TBL] [Abstract][Full Text] [Related]
15. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis. Walters DE; Chapman CD; Howard SG J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Commissiong JW; Slimovitch C; Toffano G Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171 [TBL] [Abstract][Full Text] [Related]
17. Circling behaviour in rats with unilateral lesions of the nigrostriatum induced by 6-hydroxydopamine: changes induced by oral administration of cytidine-5'-diphosphocholine. Saligaut C; Daoust M; Moore N; Boismare F Neuropharmacology; 1987 Sep; 26(9):1315-9. PubMed ID: 3118233 [TBL] [Abstract][Full Text] [Related]
18. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites. Kito S; Shimoyama M; Arakawa R Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204 [TBL] [Abstract][Full Text] [Related]
19. Apomorphine-induced stereotyped biting in the tortoise in relation to dopaminergic mechanisms. Andersen H; Braestrup C; Randrup A Brain Behav Evol; 1975; 11(5-6):365-73. PubMed ID: 1238150 [TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat. Scavone C; De Lucia R; Bernardi MM; Aizenstein ML Eur J Pharmacol; 1985 May; 112(1):11-6. PubMed ID: 4040467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]